Reversal effect and mechanism of metformin on endothelial cell dysfunction induced by intermittent high glucose

Hui-jie AN,Tian-pei HONG,Guang WANG,Rui WEI,Ye LIU,Jin YANG,Lin ZHANG

DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2013.04.010

2013-01-01

Abstract:Objective To investigate the effect and mechanism of metformin on endothelial cell damages induced by intermittent high glucose.Methods Cultured human umbilical vein endothelial cells (HUVECs) were divided into six groups:normal glucose control,hyperosmotic control,constant high glucose,fluctuating high glucose,fluctuating high glucose + metformin and fluctuating high glucose +metformin + compound C.After incubation for 72 h,the level of nitric oxide (NO) production was shown as cell supernatant nitrite concentration which was measured by nitrate reductase method; the intracellular level of reactive oxygen species (ROS) was detected by flow cytometry; and the expression levels of adenosine monophosphate activated protein kinase (AMPK),phospho-AMPK (Thr-172,p-AMPK) and guanosine 5'-triphosphate cyclohydrolase-1 (GTPCH1) proteins were determined by western blot.One-way analysis of variance and Q test were applied to analyze the differences among the groups.Results (1) Compared with those in the normal glucose control group (100％),the level of intracellular ROS ((222 ± 62) ％) was increased and the level of NO ((70.3 ± 7.1) ％) was reduced in the fluctuating high glucose group.The level of intracellular ROS ((100 ± 17)％) was decreased and the level of NO ((96.3 ± 9.2) ％) was increased in the fluctuating high glucose group by adding mefformin.The level of intracellular ROS (167.2 ± 19.6) ％) was increased and the level of NO ((83.3 ± 8.7)％) was decreased by further adding compound C,an AMPK inhibitor.All the differences were statistically significant (all P ＜ 0.05).(2) Compared with those in the normal glucose control group,the expression levels of p-AMPK ((1.72 ±0.08) vs (2.34 ±0.09)) and GTPCH1 ((4.07 ±0.17) vs (7.83 ±0.56) ) were significantly downregulated in the fluctuating high glucose group.The expression levels of p-AMPK (2.72 ± 0.22) and GTPCH1 (10.24 ± 1.05) were increased in the fluctuating high glucose group by adding metformin.The expression level of GTPCH1 (2.39 ± 0.34) was decreased by further adding compound C.All the differences were statistically significant (all P ＜0.05).Conclusion Metformin may attenuate intermittent high glucose-induced endothelial dysfunction via upregulating GTPCH1 expression mediated by activation of AMPK signaling pathway.